Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.6 HKD | +1.59% | +6.44% | +22.49% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.49% | 1.05B | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-8.86% | 33.03B | |
+55.32% | 24.68B | |
-16.44% | 15.12B | |
-8.89% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Transcript : Everest Medicines Limited, H1 2023 Earnings Call, Aug 24, 2023